Requiring undesignated or stock epinephrine for all children raises safety concerns, as epinephrine is a medication intended to be administered based on a specific medical need and diagnosis. Administering epinephrine without a child-specific prescription, documented allergy, or individualized health care plan increases the risk of inappropriate dosing, adverse reactions, and delayed emergency response. For children without a known allergy, the potential risks may outweigh the benefits. Ensuring that epinephrine is available for children with documented allergies and proper authorization is a safer and more appropriate approach.